中华器官移植杂志
中華器官移植雜誌
중화기관이식잡지
CHINESE JOURNAL OF ORGAN TRANSPLANTATION
2012年
3期
174-177
,共4页
陈恕求%陈明%许斌%任全%王奕铎%王旭辉%李宪昌
陳恕求%陳明%許斌%任全%王奕鐸%王旭輝%李憲昌
진서구%진명%허빈%임전%왕혁탁%왕욱휘%리헌창
小鼠%胰岛移植%抗原,OX40%抗原,CD40%移植物存活
小鼠%胰島移植%抗原,OX40%抗原,CD40%移植物存活
소서%이도이식%항원,OX40%항원,CD40%이식물존활
Mice%Islets of langerhans transplantation%Antigens,OX40%Antigens,CD40%Graft survival
目的 研究阻断OX40/OX40L和CD40/CD154L协同共刺激通路对小鼠胰岛移植物存活的影响及其机制.方法 以DBA/2小鼠为供者,C57BL/6小鼠为受者,制作胰岛移植模型.受鼠分为4组.(1)对照组,注射IgG; (2)抗OX40组,注射抗OX40L单克隆抗体;(3)抗CD154组,注射抗CD154单克隆抗体;(4)联合治疗组,注射抗OX40L单克隆抗体和抗CD1 54单克隆抗体.记录各组胰岛移植物平均存活时间(MST).将CD154敲除小鼠处死,取其脾脏T淋巴细胞,体外检测活化T淋巴细胞表面OX40的表达;在活化T淋巴细胞中加入不同浓度的抗OX40L单克隆抗体,体外检测T淋巴细胞增殖情况.结果 对照组胰岛移植物MST为19 d,抗CD154组胰岛移植物MST为48 d(P<0.05);抗OX40组胰岛移植物MST为22 d,与前两组相比较,差异无统计学意义(P>0.05);联合治疗组胰岛移植物MST> 150 d,高于另外3组(P<0.05).66%的胞表达OX40,较初始T淋巴细胞的表达率高(2%,P<0.05);加入抗OX40L单克隆抗体后,T淋巴细胞增殖受抑制且呈剂量依赖性.结论 阻断OX40/OX40L和CD40/CD154L双通路可诱导小鼠胰岛移植物长期存活, 其发挥作用的关键机制是抑制了T淋巴细胞的增殖.
目的 研究阻斷OX40/OX40L和CD40/CD154L協同共刺激通路對小鼠胰島移植物存活的影響及其機製.方法 以DBA/2小鼠為供者,C57BL/6小鼠為受者,製作胰島移植模型.受鼠分為4組.(1)對照組,註射IgG; (2)抗OX40組,註射抗OX40L單剋隆抗體;(3)抗CD154組,註射抗CD154單剋隆抗體;(4)聯閤治療組,註射抗OX40L單剋隆抗體和抗CD1 54單剋隆抗體.記錄各組胰島移植物平均存活時間(MST).將CD154敲除小鼠處死,取其脾髒T淋巴細胞,體外檢測活化T淋巴細胞錶麵OX40的錶達;在活化T淋巴細胞中加入不同濃度的抗OX40L單剋隆抗體,體外檢測T淋巴細胞增殖情況.結果 對照組胰島移植物MST為19 d,抗CD154組胰島移植物MST為48 d(P<0.05);抗OX40組胰島移植物MST為22 d,與前兩組相比較,差異無統計學意義(P>0.05);聯閤治療組胰島移植物MST> 150 d,高于另外3組(P<0.05).66%的胞錶達OX40,較初始T淋巴細胞的錶達率高(2%,P<0.05);加入抗OX40L單剋隆抗體後,T淋巴細胞增殖受抑製且呈劑量依賴性.結論 阻斷OX40/OX40L和CD40/CD154L雙通路可誘導小鼠胰島移植物長期存活, 其髮揮作用的關鍵機製是抑製瞭T淋巴細胞的增殖.
목적 연구조단OX40/OX40L화CD40/CD154L협동공자격통로대소서이도이식물존활적영향급기궤제.방법 이DBA/2소서위공자,C57BL/6소서위수자,제작이도이식모형.수서분위4조.(1)대조조,주사IgG; (2)항OX40조,주사항OX40L단극륭항체;(3)항CD154조,주사항CD154단극륭항체;(4)연합치료조,주사항OX40L단극륭항체화항CD1 54단극륭항체.기록각조이도이식물평균존활시간(MST).장CD154고제소서처사,취기비장T림파세포,체외검측활화T림파세포표면OX40적표체;재활화T림파세포중가입불동농도적항OX40L단극륭항체,체외검측T림파세포증식정황.결과 대조조이도이식물MST위19 d,항CD154조이도이식물MST위48 d(P<0.05);항OX40조이도이식물MST위22 d,여전량조상비교,차이무통계학의의(P>0.05);연합치료조이도이식물MST> 150 d,고우령외3조(P<0.05).66%적포표체OX40,교초시T림파세포적표체솔고(2%,P<0.05);가입항OX40L단극륭항체후,T림파세포증식수억제차정제량의뢰성.결론 조단OX40/OX40L화CD40/CD154L쌍통로가유도소서이도이식물장기존활, 기발휘작용적관건궤제시억제료T림파세포적증식.
Objective To investigate the effects of blockade of OX40/OX40L costimulation pathway on mice islet allograft tolerance in CD40/CD154 costimulation pathway blockade mice.Methods C57BL/6 mice were induced into diabetes mellitus as recipients,and were transplanted with DBA/2 mice islets.The recipients were divided into four groups,(1) treated with IgG as controls,(2) anti-OX40L mAb,(3) anti-CD154,(4) combined treatment of anti-OX40L mAb and anti CD154mAb.The mean survival time (MST) of islet allograft was observed.The expression of OX40 in activated T cells of CD154 deficient mice was detected.Effector T cells were obtained from the spleen of CD154 deficient mice cultured with or without anti-OX40L mAb for 3 days.The proliferation of T cells was assayed.Results The MST in the control group,anti-OX40L mAb group,anti-CD154 mAb group and anti OX40L mAb + anti-CD154 mAb group was 19,22,48,and >150 days respectively (P <0.05).The OX40 expression was readily induced in the 66% activated T effector cells.CD154 deficient T effector cells proliferation was inhibited by the addition of anti-OX40L mAb in the culture in a dose-dependent fashion.Conclusion The blockade of OX40/OX40L costimulation pathway can promote islet allograft tolerance in CD40/CD154 costimulation pathway blockade mice by inhibiting the proliferation of T cells.